Artificial Intelligence | Machine Learning | Natural Language Processing Gero | AI-Driven Drug Discovery and Drug Repurposing

Enterprise, Pharmaceuticals, Biotechnology, Drug Development, Digital Health, Target Identification Singapore, Central Region, Singapore

Artificial Intelligence | Machine Learning | Natural Language Processing

Gero | AI-Driven Drug Discovery and Drug Repurposing

Pharmaceuticals, Biotechnology, Drug Development, Digital Health, Target Identification

Singapore, Central Region, Singapore

Gero is a longevity biotech company founded by a team of scientists and entrepreneurs with extensive experience in the area of life sciences. Our goal is to extend healthy lifespan dramatically and delay age-related health issues.

We identify novel anti-aging targets, develop life-extending therapies and estimate personal risks of diseases and mortality with the help of AI and proprietary models.

N/A

26 to 50

Series A

$2,200,000

N/A

2015

Pharmaceuticals and Medical Products
Healthcare

N/A

Yes

Active

Machine Learning
Natural Language Processing

Big Data

Digital Health Platform

Predictive Analytics

N/A

Software

HTML

API

Neural Networks

Maxim Kholin
Co-Founder

Yuri Deigin
COO

Sergei Filonov
Co-founder and Chief Visionary Officer

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Gero

Gero - Manage Profile